VIM and neoplasm: These data suggest that the ubiquitin-like domain, or the vimentin binding domain, is indispensable for FRMD3 to elicit its anti-tumor effects on BRCA, which further verified that the downregulation of vimentin was at least one of the key mechanisms underlying FRMD3’s tumor suppressive effects on BRCA.